Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
OTOP2 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
USH1G - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
HID1 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
GEO DataSets Gene Chromosome neighbors Homologene neighbors
FDXR - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
CDR2L - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
GRIN2C - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
MRPL58 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
ATP5H - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
TMEM104 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
KCTD2 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
NAT9 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
SLC9A3R1 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
RAB37 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
CD300LF - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on